CTRI/2024/02/062381尚未招募2 期
Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India - NI
ational Institutes of Health, National Cancer Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 WLH, 25 to 50 years of age per HIV-based guidelines 2 receiving ART for over two months to ensure medication stabilization, validated by an ART card given to all ART patients 3 screened as HPV positive with self sample vaginal collection 4 assessed to have oncogenic HPV and 5 assessed to be VIA negative for cervical lesions, performed by our trained Auxiliary Nurse Midwife (ANM)
排除标准
- •1 pregnant or lactating women due to hormonal and dietary guideline differences 2 women below 25 years and 3 women determined to be VIA positive as they will be immediately referred to our Gynecology specialist.
研究者
相似试验
招募中
不适用
Prevention of Cervical Cancer (PRECERCA 1)CTRI/2022/10/046796Cepheid India
招募中
不适用
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer ScreeningHPVNCT06109870M.D. Anderson Cancer Center920
已完成
不适用
Combined Incentive Actions, Focusing on Primary Care, to Improve Cervical Cancer Screening in Women Residing in Socio-economically Disadvantaged and Untracked Geographical Areas: a Hybrid Efficacy and Implementation TrialCervical CancerNCT04312178Centre Hospitalier Universitaire Dijon10,446
撤回
2 期
Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer PatientsCervical NeoplasmsNCT00950261Korea Cancer Center Hospital
尚未招募
2 期
Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical CancerCervical CancerNCT06039891Peking Union Medical College Hospital55